Compare New GLP-1 Agonist and Flozin Options for Type 2 Diabetes

You'll see more players join the crowded field of type 2 diabetes meds...Bydureon BCise, Ozempic (oh-ZEM-pik), Steglatro (steh-GLAH-troh).

Bydureon BCise (exenatide ER) and Ozempic (semaglutide) will bring the total to eight GLP-1 agonists. Both are once-WEEKLY injections.

Bydureon BCise is extended-release exenatide, like Bydureon. You'll hear it gives more consistent drug levels in a simpler pen device.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote